Prosecution Insights
Prosecution Insights
Technology areas: Biotechnology & Pharmaceuticals • Chemistry & Materials
16 pending office actions • 9 art units • 15 examiners • 0 of 16 (0%) have an AI response strategy ready • 13 patents granted in the last 365 days
International N&h Denmark Aps is navigating 15 pending office actions within the Biotechnology & Pharmaceuticals technology area. These actions are spread across 14 distinct examiners and 8 distinct art units. This distribution shows a broad engagement with the patent office, involving many different technical reviewers and administrative groups. The presence of 15 pending office actions indicates a significant and active interest in securing intellectual property within the biotechnology sector.
The busiest examiner, ZEMAN, ROBERT A, is responsible for 2 busiest examiner pending actions. The remaining actions from the total of 15 pending office actions are managed by the other distinct examiners. This indicates that while ZEMAN, ROBERT A has a slightly higher workload, the majority of the 14 distinct examiners are handling fewer actions across the 8 distinct art units. For practitioners, this means that the company's prosecution strategy must be adaptable to various technical standards and administrative procedures. The concentration of 2 actions with ZEMAN, ROBERT A represents the only instance of examiner overlap in the current 15 pending office actions, suggesting a highly diversified prosecution landscape.
Based on the USPTO statutory response window for each pending office action. 4 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 4 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 3 (19%) |
| §112 only | 1 (6%) |
| Double-patenting + other | 5 (31%) |
| Multi-statute (no §101) | 7 (44%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| ZEMAN, ROBERT A | 2 | 54.3% | +27.7% |
| NOAKES, SUZANNE MARIE | 1 | 73.3% | +18.2% |
| BEKKER, KELLY JO | 1 | 16.7% | +35.4% |
| PYLA, EVELYN Y | 1 | 55.7% | +47.1% |
| DAVIS, RUTH A | 1 | 60.8% | +31.1% |
| KERSHAW, KELLY P | 1 | 17.7% | +16.0% |
| HEINCER, LIAM J | 1 | 55.8% | +26.0% |
| DEVI, SARVAMANGALA | 1 | 65.3% | +55.3% |
| LEBLANC, KATHERINE DEGUIRE | 1 | 34.6% | +35.8% |
| WHITE, ASHLEY TAYLOR | 1 | 25.0% | +46.7% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18750902 | SUGAR MIXTURES AND METHODS FOR PRODUCTION AND USE THEREOF | HEINCER, LIAM J | 5d overdue |
| 18897841 | MEAT PRODUCT | BEKKER, KELLY JO | 7d |
| 18792084 | ANTI-OXIDANT COMPOSITION | KERSHAW, KELLY P | — |
| 18711238 | PRODUCTION OF HIGHLY ATTENUATED BEERS | LEBLANC, KATHERINE DEGUIRE | — |
| 18696298 | EFFECT OF A PROBIOTIC COMPOSITION ON VAGINAL LACTOBACILLUS SPECIES | ZEMAN, ROBERT A | — |
| 18590736 | GLYCOSIDE HYDOLASES AND THEIR USE IN PREVENTING AND/OR TREATING A PATHOGENIC INFECTION IN AN ANIMAL | WHITE, ASHLEY TAYLOR | — |
| 18580713 | PROBIOTICS FOR USE IN BOOSTING THE IMMUNE SYSTEM | DUFFY, PATRICIA ANN | — |
| 18580960 | LACTOCOCCUS STRAINS | LI, CHANGQING | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18750902 | SUGAR MIXTURES AND METHODS FOR PRODUCTION AND USE THEREOF | HEINCER, LIAM J | 5d overdue |
| 18897841 | MEAT PRODUCT | BEKKER, KELLY JO | 7d |
| 18566194 | BACTERIAL STRAINS FOR USE IN PREVENTING, TREATING AND/OR REDUCING SYMPTOMS ASSOCIATED WITH A RHINOVIRUS-INDUCED COLD INFECTION | ZEMAN, ROBERT A | 9d |
| 19103587 | EXPRESSION SYSTEMS FOR PHOSPHATASES | NOAKES, SUZANNE MARIE | — |
| 18804707 | METHOD OF TREATMENT | PYLA, EVELYN Y | — |
| 18836135 | USE OF PROBIOTICS FOR MODULATING ALLERGIC IMMUNE RESPONSES | DAVIS, RUTH A | — |
| 18792084 | ANTI-OXIDANT COMPOSITION | KERSHAW, KELLY P | — |
| 18714926 | LACTOBACILLI FOR SKIN AGING | DEVI, SARVAMANGALA | — |
| Art Unit | Apps |
|---|---|
| 1645 | 4 |
| 1791 | 2 |
| 1652 | 1 |
| 1792 | 1 |
| 1767 | 1 |
| 1653 | 1 |
| 1634 | 1 |
| 1656 | 1 |
| 1651 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 19103587 | EXPRESSION SYSTEMS FOR PHOSPHATASES | NOAKES, SUZANNE MARIE | 1652 | §103 | Non-Final OA | — | Pending | Feb 13, 2025 |
| 18897841 | MEAT PRODUCT | BEKKER, KELLY JO | 1792 | §103 | Non-Final OA | 7d | Pending | Sep 26, 2024 |
| 18804707 | METHOD OF TREATMENT | PYLA, EVELYN Y | — | §112DP | Non-Final OA | — | Pending | Aug 14, 2024 |
| 18836135 | USE OF PROBIOTICS FOR MODULATING ALLERGIC IMMUNE RESPONSES | DAVIS, RUTH A | — | §102§103§112DP | Non-Final OA | — | Pending | Aug 06, 2024 |
| 18792084 | ANTI-OXIDANT COMPOSITION | KERSHAW, KELLY P | — | §103 | Non-Final OA | — | Pending | Aug 01, 2024 |
| 18750902 | SUGAR MIXTURES AND METHODS FOR PRODUCTION AND USE THEREOF | HEINCER, LIAM J | 1767 | §103§112Other | Final Rejection | 5d overdue | Pending | Jun 21, 2024 |
| 18714926 | LACTOBACILLI FOR SKIN AGING | DEVI, SARVAMANGALA | 1645 | §102§112DP | Non-Final OA | — | Pending | May 30, 2024 |
| 18711238 | PRODUCTION OF HIGHLY ATTENUATED BEERS | LEBLANC, KATHERINE DEGUIRE | 1791 | §102§103 | Non-Final OA | — | Pending | May 17, 2024 |
| 18696298 | EFFECT OF A PROBIOTIC COMPOSITION ON VAGINAL LACTOBACILLUS SPECIES | ZEMAN, ROBERT A | 1645 | §102§112 | Non-Final OA | — | Pending | Mar 27, 2024 |
| 18590736 | GLYCOSIDE HYDOLASES AND THEIR USE IN PREVENTING AND/OR TREATING A PATHOGENIC INFECTION IN AN ANIMAL | WHITE, ASHLEY TAYLOR | 1653 | §103§112DP | Non-Final OA | — | Pending | Feb 28, 2024 |
| 18580713 | PROBIOTICS FOR USE IN BOOSTING THE IMMUNE SYSTEM | DUFFY, PATRICIA ANN | 1645 | §102§103 | Non-Final OA | — | Pending | Jan 19, 2024 |
| 18580960 | LACTOCOCCUS STRAINS | LI, CHANGQING | 1791 | §102§103§112 | Non-Final OA | — | Pending | Jan 19, 2024 |
| 18569795 | CELL CULTURE METHODS | PENNINGTON, KATIE LEIGH | 1634 | §102§103§112 | Non-Final OA | — | Pending | Dec 13, 2023 |
| 18566194 | BACTERIAL STRAINS FOR USE IN PREVENTING, TREATING AND/OR REDUCING SYMPTOMS ASSOCIATED WITH A RHINOVIRUS-INDUCED COLD INFECTION | ZEMAN, ROBERT A | 1645 | §112 | Final Rejection | 9d | Pending | Dec 01, 2023 |
| 18351069 | ENZYMATIC MODIFICATION OF PHOSPHOLIPIDS IN FOOD | JONES-FOSTER, ERICA NICOLE | 1656 | §103§112DP | Final Rejection | 23d overdue | Pending | Jul 12, 2023 |
| 17287619 | ENZYMES FOR INFUSION MASHING IN ADJUNCT BREWING TECHNICAL FIELD | GOUGH, TIFFANY MAUREEN | 1651 | §103§112 | Final Rejection | — | Pending | Apr 22, 2021 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial